Safety of Submacular Suprachoroidal Drug Administration via a Microcatheter: Retrospective Analysis of European Treatment Results
- 21 February 2012
- journal article
- case report
- Published by S. Karger AG in Ophthalmologica
- Vol. 227 (4) , 183-189
Abstract
Purpose: To investigate the safety and feasibility of using a microcatheter for drug delivery in the suprachoroidal space in eyes with advanced, exudative, age-related macular degeneration (AMD) unresponsive to conventional therapy. Procedures: A unique microcatheter was used to deliver a drug combination consisting of bevacizumab and triamcinolone to the submacular suprachoroidal space. Twenty-one eyes of 21 patients with choroidal neovascularization (CNV) secondary to advanced, exudative AMD were followed over a 6-month postprocedure period. Results: The microcatheter was successfully and atraumatically inserted into the suprachoroidal space of all eyes. No serious intraoperative or postoperative complications including suprachoroidal hemorrhages were encountered. Postsurgically, complications consisted of 1 eye experiencing a transient elevation in intraocular pressure at 3 months, which was medically controlled, and 2 eyes (10.5%) with an apparent increase in nuclear sclerotic cataracts. Conclusions: Suprachoroidal drug administration was achieved without serious complication using a novel microcatheter. Direct drug delivery to the choroid can potentially increase local tissue drug levels and drug efficacy for the treatment of AMD and other diseases associated with CNV.Keywords
This publication has 13 references indexed in Scilit:
- COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSIONRetina, 2010
- Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injectionEye, 2009
- Die Therapie der vaskularisierten serösen Pigmentepithelabhebung bei AMD – Beobachtungen nach Wechsel des intravitrealen Medikamentes bei TherapieversagenKlinische Monatsblätter für Augenheilkunde, 2008
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal NeovascularizationOphthalmology, 2008
- Injection intravitréenne : évaluation rétrospective de la technique et des complications d’une série de 2028 injectionsJournal Français d'Ophtalmologie, 2008
- Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)Graefe's Archive for Clinical and Experimental Ophthalmology, 2007
- The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degenerationIndian Journal Of Ophthalmology, 2007
- Cannulation of the Suprachoroidal Space: A Novel Drug Delivery Methodology to the Posterior SegmentAmerican Journal of Ophthalmology, 2006
- Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology, 2003
- Argon Laser Photocoagulation for Neovascular MaculopathyArchives of Ophthalmology (1950), 1991